UNSPSC 51401803: Premazepam

This classification denotes a benzodiazepine with the molecular formula C15H15N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OI7443PDLB, chemically known as 3,7-dihydro-6,7-dimethyl-5-phenylpyrrolo(3,4-e)(1,4)diazepin-2(1h)-one but generally known as premazepam, which bears US NIH Compound Identifier 72104. European Medicines Agency schedules Premazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10026MIG.

UNSPSC 51401803 Premazepam is a Commodity code that describes pharmaceutical products state and local governments procure for public health programs and pharmacy benefit operations. However, the recent solicitations tagged to this code do not reflect premazepam specifically; instead, they document state and local procurement of naloxone, generic multi-source pharmaceuticals, and over-the-counter products. The mismatch suggests either a coding classification error in the source records or a broader pharmaceutical-supply categorization that spans active pharmaceutical ingredients and finished-goods formulations. State and local buyers under this code tier include county health departments, state health and human services agencies, and cooperative purchasing alliances that serve multi-state networks of public entities.

Recent activity centers on Florida, Texas, and Minnesota. Seminole County, Florida released IFB 60459723LAS on June 30, 2026 (due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the county community health building, with a two-year initial term plus one-year renewal option. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, exploring vendor experience with direct contracting for self-insured employer and state agency health plans outside traditional pharmacy benefit manager arrangements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, released an RFP on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local facilities in Minnesota, Oregon, and other partner jurisdictions, with awarded vendors taking effect July 1, 2026 and serving AmerisourceBergen, Cardinal Health, and Morris & Dickson as authorized wholesalers. The code shows sparse, scattered recent activity with no clear concentration of repeat issuing bodies or geographic clusters beyond these three distinct procurement vehicles.